AEON Biopharma, Inc. (AEON) Operating income 2021–2025
AEON Biopharma, Inc. (AEON) annual operating income history from SEC filings — each fiscal year as reported.
-$12.8MFY2025 · since FY2021: -$1.9M → -$12.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.8M | -117.5% |
| FY2024 | $73.0M | — |
| FY2022 | -$48.4M | -2401.6% |
| FY2021 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AEON financial trends
AEON RevenueAEON Net incomeAEON Net marginAEON Gross profitAEON Gross marginAEON Operating marginAEON Operating cash flowAEON Free cash flowAEON Capital expendituresAEON Return on equityAEON Stock buybacksAEON Dividends paidAEON Total assetsAEON Total liabilitiesAEON Shareholders’ equityAEON overview →